Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Wyświetlane elementy: 4 z 8

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA Hilge to wszechstronna oferta pomp odśrodkowych i wyporowych przeznaczonych do szerokiej gamy wrażliwych procesów w branży żywności, napojów i alkoholi oraz w przemyśle farmaceutycznym.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

Innowacyjne koncepcje mycia typu CIP od GEA spełniają kompleksowe wysokie standardy Nasi eksperci gwarantują bezpieczeństwo produktu na każdym etapie procesu. Każda modernizacji jest dostosowywana do warunków lokalnych oraz wymagań klienta, co zapewnia znaczne oszczędności.
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
Był taki czas, kiedy frazy „piwo bezalkoholowe” oraz „smakuje dobrze” bardzo rzadko pojawiały się w tym samym zdaniu, zwłaszcza w ustach konsumentów. Ale sektor piw o niskiej zawartości alkoholu i bezalkoholowych zdążył przejść bardzo długą drogę – wiele tego typu produktów to obecnie ożywcze napoje tworzące osobną kategorię – w dużej mierze dzięki technologii GEA.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.